Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...

DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.

Dexcom (Nadsaq:DXCM) announced today that it received a warning letter from the FDA following inspections of two company ...

DexCom (NasdaqGS:DXCM) recently received a warning letter from the FDA, which pointed out issues in manufacturing processes and quality management. While these regulatory developments did not impact ...

DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San ...

In a regulatory filing, DexCom (DXCM) disclosed that on March 4, the company received a warning letter from the U.S. FDA following inspections ...

The U.S. Department of Agriculture has dissolved two key food safety advisory committees, sparking concern over government ...

EST DexCom (DXCM) falls 7% to $71.99 after receiving warning letter from FDADiscover the Best Stocks and Maximize Your Portfolio: See ...

The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...

The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...

The Kansas City Chiefs suffered an embarrassing defeat at the hands of the Philadelphi Eagles, losing Super Bowl LIX, 40-22.

However, this freedom does have some caveats. FDA Approves Dexcom’s Stelo Glucose Biosensor System As An OTC Glucometer The ...